person · Reporting owner
Correia de Simas Jose Manuel
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elanco Animal Health IncELAN · Entity 3457 | SEE REMARKS | March 06, 2026 | March 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elanco Animal Health Inc
Report date March 06, 2026 · Filed March 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Stock UnitsSEC Table II · derivative / convertible security | Direct | 22,280.4709 |
Reported balance
After 2026-03-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-06 · Grant · Acquired 17,637.8425 · Balance 22,280.4709 F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 10, 2026 16:14 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 17,637.8425 | $23.36 | $412,020.00 |
DisclosureSEC source: 0001809748-26-000006 · form4-03102026_080306.xml · derivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,280.4709 Underlying: Common Stock · 17,637.8425 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 16:13 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 3,371 | $24.88 | $83,870.48 |
DisclosureSEC source: 0001809748-26-000004 · form4-03052026_090335.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,017 Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 19:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units (Match) · Derivative | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001809748-26-000002 · form4-03042026_120304.xml · derivative · entry 5 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 937 Underlying: Common Stock · 937 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F4 · derivative.exercise_date: Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. F4 · derivative.expiration_date: Deferred stock units vest December 31, 2027 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 19:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 23,220 | $0.00 Strike: $26.40 | $0.00 |
DisclosureSEC source: 0001809748-26-000002 · form4-03042026_120304.xml · derivative · entry 4 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,220 Underlying: Common Stock · 23,220 shares Expires 2036-03-01 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 19:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 11,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001809748-26-000002 · form4-03042026_120304.xml · nonDerivative · entry 3 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,388 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 19:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 9,883 | $26.40 | $260,911.20 |
DisclosureSEC source: 0001809748-26-000002 · form4-03042026_120304.xml · nonDerivative · entry 2 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,024 Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 19:18 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 21,507 | $0.00 | $0.00 |
DisclosureSEC source: 0001809748-26-000002 · form4-03042026_120304.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,907 Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 17:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units · Derivative | 4,642.6284 | $11.14 | $51,718.88 |
DisclosureSEC source: 0001415889-25-007678 · form4-03112025_090359.xml · derivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,642.6284 Underlying: Common Stock · 4,642.6284 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F2 · derivative.exercise_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. F2 · derivative.expiration_date: Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 18:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantDeferred Stock Units (Match) · Derivative | 1,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007087 · form4-03052025_110316.xml · derivative · entry 3 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires not disclosed F3 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. F4 · derivative.exercise_date: Deferred stock units vest December 31, 2026 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. F4 · derivative.expiration_date: Deferred stock units vest December 31, 2026 and settle upon termination of employment or otherwise in accordance with the Executive Deferral and Stock Match Plan. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 18:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 46,383 | $0.00 Strike: $11.31 | $0.00 |
DisclosureSEC source: 0001415889-25-007087 · form4-03052025_110316.xml · derivative · entry 2 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,383 Underlying: Common Stock · 46,383 shares Expires 2035-03-03 F2 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 18:51 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 22,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007087 · form4-03052025_110316.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,400 F1 · shares: Grant of restricted stock units vesting as follows: one-third vesting on March 3, 2026, one-third vesting on March 3, 2027, and the remaining vesting on March 3, 2028. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 17:29 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 4,747 | $11.17 | $53,023.99 |
DisclosureSEC source: 0001415889-25-006622 · form4-03042025_100319.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,295 Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 18:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 11,808 | $11.24 | $132,721.92 |
DisclosureSEC source: 0001415889-25-005165 · form4-02212025_110233.xml · nonDerivative · entry 2 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,042 Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 18:15 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 26,082 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-005165 · form4-02212025_110233.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,850 Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:25 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option(right to buy) · Derivative | 22,109 | $0.00 Strike: $16.03 | $0.00 |
DisclosureSEC source: 0001415889-24-006637 · form4-03052024_090300.xml · derivative · entry 3 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,109 Underlying: Common Stock · 22,109 shares Expires 2034-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:25 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 3,642 | $16.03 | $58,381.26 |
DisclosureSEC source: 0001415889-24-006637 · form4-03052024_090300.xml · nonDerivative · entry 2 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,768 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:25 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 10,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-006637 · form4-03052024_090300.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,410 F1 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 18:22 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 4,044 | $16.46 | $66,564.24 |
DisclosureSEC source: 0001415889-24-005967 · form4-02292024_110228.xml · nonDerivative · entry 2 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,272 Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 18:22 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 8,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-005967 · form4-02292024_110228.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,316 Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 17:17 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 2,239 | $10.06 | $22,524.34 |
DisclosureSEC source: 0001415889-23-010795 · form4-07052023_090725.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,706 Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 18:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 6,801 | $11.01 | $74,879.01 |
DisclosureSEC source: 0001415889-23-004352 · form4-03062023_110339.xml · nonDerivative · entry 2 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,945 Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 18:49 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 15,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004352 · form4-03062023_110339.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,746 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option (right to buy) · Derivative | 32,962 | $0.00 Strike: $11.26 | $0.00 |
DisclosureSEC source: 0001415889-23-004280 · form4-03042023_010306.xml · derivative · entry 3 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,962 Underlying: Common Stock · 32,962 shares Expires 2033-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 14,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004280 · form4-03042023_010306.xml · nonDerivative · entry 2 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,639 F2 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2023, one-third vesting on March 1, 2024, one-third vesting on March 1, 2025, and the remaining vesting on March 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 20:59 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 1,400 | $11.26 | $15,764.00 |
DisclosureSEC source: 0001415889-23-004280 · form4-03042023_010306.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,207 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| July 01, 2022 Filed Jul 6, 2022 18:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 2,172 | $20.62 | $44,786.64 |
DisclosureSEC source: 0001415889-22-007520 · form4-07062022_030739.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,607 F1 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantEmployee Stock Option(right to buy) · Derivative | 13,614 | $0.00 Strike: $28.94 | $0.00 |
DisclosureSEC source: 0001415889-22-002474 · form4-03032022_060314.xml · derivative · entry 3 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,614 Underlying: Common Stock · 13,614 shares Expires 2032-03-01 F3 · derivative.exercise_date: Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 573 | $28.94 | $16,582.62 |
DisclosureSEC source: 0001415889-22-002474 · form4-03032022_060314.xml · nonDerivative · entry 2 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,779 F2 · shares: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:03 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 5,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002474 · form4-03032022_060314.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · SEE REMARKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,352 F1 · shares: Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 17:06 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | Tax withholdingCommon Stock | 1,425 | $35.00 | $49,875.00 |
DisclosureSEC source: 0000950138-21-000376 · edgar.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,229 F1 · price: Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 19:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 3,552 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-21-000188 · edgar.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,654 F1 · price: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2021, one-third vesting on March 1, 2022, one-third vesting on March 1, 2023, and the remaining vesting on March 1, 2024. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 16:10 UTC | Elanco Animal Health Inc ELAN · Entity 3457 | GrantCommon Stock | 15,102 | $0.00 | $0.00 |
DisclosureSEC source: 0000950138-20-000306 · edgar.xml · nonDerivative · entry 1 Correia de Simas Jose Manuel · CIK 0001809748 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,102 F1 · price: Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on July 1, 2020, one-third vesting on July 1, 2021, one-third vesting on July 1, 2022, and the remaining vesting on July 1, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.